Quantitative determination of famotidine in human maternal plasma, umbilical cord plasma and urine using high-performance liquid chromatography-mass spectrometry

Biomedical Chromatography

Volumn 27, Issue 7, 2013, Pages 866-873

  Wang, Xiaoming ^a   Rytting, Erik ^a   Abdelrahman, Doaa R ^a   Nanovskaya, Tatiana N ^a   Hankins, Gary D V ^a   Ahmed, Mahmoud S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Famotidine; LC MS; Pregnancy; Umbilical cord plasma; Urine

Indexed keywords

BODY FLUIDS; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

FAMOTIDINE; HUMAN URINE; LC-MS; MATERNAL PLASMAS; PLASMA SAMPLES; PREGNANCY; QUANTITATIVE DETERMINATIONS; UMBILICAL-CORD PLASMA; URINE; URINE SAMPLE;

AMMONIUM HYDROXIDE;

ACETIC ACID ETHYL ESTER; AMMONIUM ACETATE; AMMONIUM HYDROXIDE; FAMOTIDINE;

ACCURACY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SELECTIVITY; DRUG STABILITY; DRUG URINE LEVEL; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; MATERNAL PLASMA; STEADY STATE; UMBILICAL CORD BLOOD;

EID: 84878962203     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2873     Document Type: Article

References (18)

1. Ali RAR. Gastroesophageal reflux disease in pregnancy. Best Practice and Research Clinical Gastronenterology 2007; 21: 793-806.
2. Almdida AM, Castel-Branco MM and Falcao AC. Linear regression for calibration lines revised: weighting schemes for bioanalytical methods. Journal of Chromatography B 2002; 774: 215-222.
3. Anzenbacherova E, Filipova K, Nobilis M and Anzenbacher P. Selective determination of famotidine in human plasma by high performance liquid chromatography in alkaline media with solid phase extraction. Journal of Separation Science 2003; 26: 722-726.
4. Baron TH, Ramirez B and Richter JE. Gastrointestinal motility disorders during pregnancy. Annals of Internal Medicine 1993; 118: 336-375.
5. Campanero MA, Bueno I, Arangoa MA, Escolar M, Quetglas EG, Lopez-Ocariz and Azanza JR. Improved selectivity in detection of polar basic drugs by liquid chromatography-electrospray ionization mass spectrometry. Illustration using an assay method for the determination of famotidine in human plasma. Journal of Chromatography B 2001; 763: 21-33.
6. Dowling TC and Frye RF. Determination of famotidine in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography B 1999; 732: 239-243.
7. FDA. Guidance for Industry, Bio-analytical Method Validation. Food and Drug Administration, Centre for Drug Evaluation and Research, May 2001; available from: http://www.fda.gov/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm123635.htm
8. Gill SK, O' BrienL, Einarson OR and Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. The American Journal of Gastroenterology 2009; 104: 1541-1545.
9. Howard JM, Chremos AN, Collen MJ, Mcarthur KE, Cherner JA, Maton PN, Ciarleglio CA, Cornelius MJ, Gardner JD and Jensen RT. Famotidine, a new, potent, long-acting histamine H-2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology 1985; 88: 1026-1033.
10. Perez-Ruiz T, Martinez-Lozano C, Tomas V and Galera R. Direct determination of ranitidine and famotidine by CE in serum, urine and pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis 2002; 30: 1055-1061.
11. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterology Clinics of North America 2003; 32: 235-261.
12. Shou WZ and Naidong W. Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds. Journal of Chromatography B 2005; 825: 186-192.
13. Sun X, Tian Y, Zhang Z and Chen Y. A single LC-tandem mass spectrometry method for the simultaneous determination of H2 antagonists in human plasma. Journal of Chromatography B 2009; 877: 3953-3959.
14. Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MK, Sails tad J, Shah VP, Skelly JP, Swann PG and Weiner R. Workshop/conference report - Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand biding assays. The AAPS Journal 2007; 9: E30-E42.
15. Zarghi A, Shafaati A, Foroutan SM and Khoddam A. Development of rapid HPLC method for determination of famotidine in human plasma using a monolithic column. Journal of Pharmaceutical and Biomedical Analysis 2005; 39: 677-680.
16. Zarghi A, Komeilizadeh H, Amini M and Kimiagar L. Determination of famotidine in plsma and urine by high-performance liquid chromatography. Pharmacy and Pharmacology Communications 1998; 4: 77-80.
17. Zhong L and Yeh KC. Determination of famotidine in human plasma by high-performance liquid chromatography with column switching. Journal of Pharmaceutical and Biomedical Analysis 1998; 16: 1051-1057.
18. Zhong L, Eisenhandler R and Yeh KC. Determination of famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry. Journal of Mass spectrometry 2011, 36: 736-741.